Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Sommariva M; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy. michele.sommariva@unimi.it.; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy. michele.sommariva@unimi.it., Dolci M; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy., Triulzi T; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Ambrogi F; Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Via Celoria 22, 20133, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy., De Cecco L; Integrated Biology of Rare Tumors, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Le Noci V; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Bernardo G; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Anselmi M; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Montanari E; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Pupa SM; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Signorini L; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy., Gagliano N; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Sfondrini L; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy.; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Delbue S; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy., Tagliabue E; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jun 07; Vol. 14 (1), pp. 13134. Date of Electronic Publication: 2024 Jun 07.
Autor:
Ricci A; Notified Body 0373 Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Dugo M; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Pisanu ME; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., De Cecco L; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Raspagliesi F; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy., Valeri B; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milano, Italy., Veneroni S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Chirico M; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Palombelli G; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Daidone MG; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Podo F; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Canese R; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy., Mezzanzanica D; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Bagnoli M; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy., Iorio E; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
Publikováno v:
Journal of proteome research [J Proteome Res] 2024 Jan 05; Vol. 23 (1), pp. 483-493. Date of Electronic Publication: 2023 Dec 18.
Autor:
Vallacchi V; Department of Experimental Oncology, Unit of Translational Immunology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vergani E; Department of Experimental Oncology, Unit of Translational Immunology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cossa M; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gargiuli C; Applied Research and Technology Development Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Busico A; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Devecchi A; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy., Bergamaschi L; Department of Experimental Oncology, Unit of Translational Immunology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Integrated Biology of Rare Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cavalieri S; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Valeri B; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tamborini E; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gallino G; Melanoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Del Vecchio M; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Santinami M; Melanoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sensi M; Applied Research and Technology Development Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rivoltini L; Department of Experimental Oncology, Unit of Translational Immunology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Guardo L; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rodolfo M; Department of Experimental Oncology, Unit of Translational Immunology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy monica.rodolfo@istitutotumori.mi.it.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jan 04; Vol. 12 (1). Date of Electronic Publication: 2024 Jan 04.
Autor:
Bosi C; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Bartha Á; Department of Bioinformatics, Semmelweis University, Tűzoltó Utca 7-9, 1094 Budapest, Hungary; Research Centre for Natural Sciences, Oncology Biomarker Research Group, Institute of Molecular Life Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, 1117 Budapest, Hungary., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Notini G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Naldini MM; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Licata L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Viale G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Mariani M; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Pistilli B; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France., Ali HR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK., André F; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France., Piras M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Callari M; Fondazione Michelangelo, Milan, Italy., Barreca M; Fondazione Michelangelo, Milan, Italy., Locatelli A; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Viganò L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Criscitiello C; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Pusztai L; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA., Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Győrffy B; Department of Bioinformatics, Semmelweis University, Tűzoltó Utca 7-9, 1094 Budapest, Hungary; Research Centre for Natural Sciences, Oncology Biomarker Research Group, Institute of Molecular Life Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, 1117 Budapest, Hungary., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: dugo.matteo@hsr.it., Bianchini G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: bianchini.giampaolo@hsr.it.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113379. Date of Electronic Publication: 2023 Oct 11.
Autor:
Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Barreca M; University of Milano-Bicocca, Milan, Italy., Galbardi B; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Viale G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Cancer Biomarker Research Group, Research Centre for Natural Sciences, Budapest, Hungary., Karn T; Goethe University Hospital Frankfurt, Frankfurt, Germany., Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Gianni L; Michelangelo Foundation, Milan, Italy., Callari M; Michelangelo Foundation, Milan, Italy. maurizio.callari@fondazionemichelangelo.org., Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy. bianchini.giampaolo@hsr.it.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy. bianchini.giampaolo@hsr.it.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Dec; Vol. 129 (12), pp. 2025-2033. Date of Electronic Publication: 2023 Nov 07.
Autor:
Wang XQ; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Danenberg E; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Huang CS; National Taiwan University Hospital, College of Medicine, National Taiwan University and Taiwan Breast Cancer Consortium, Taipei, Taiwan., Egle D; Department of Gynecology, Brust Gesundheit Zentrum Tirol, Medical University Innsbruck, Innsbruck, Austria., Callari M; Fondazione Michelangelo, Milan, Italy., Bermejo B; Medical Oncology, Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.; Medicine Department, Universidad de Valencia, Valencia, Spain.; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain., Dugo M; San Raffaele Hospital, Milan, Italy., Zamagni C; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy., Thill M; Department of Gynecology and Gynecological Oncology, Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany., Anton A; Hospital Universitario Miguel Servet, Zaragoza, Spain., Zambelli S; San Raffaele Hospital, Milan, Italy., Russo S; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy., Ciruelos EM; Hospital Universitario 12 de Octubre, Madrid, Spain., Greil R; 3rd Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria.; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Cancer Biomarker Research Group, Research Centre for Natural Sciences, Institute of Enzymology, Budapest, Hungary., Semiglazov V; NN Petrov Research Institute of Oncology, St. Petersburg, Russia., Colleoni M; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Kelly CM; Mater Private Hospital, Dublin and Cancer Trials Ireland Breast Group, Dublin, Ireland., Mariani G; Fondazione IRCSS - Istituto Nazionale Tumori, Milan, Italy., Del Mastro L; IRCCS Ospedale Policlinico San Martino, UO Clinica di Oncologia Medica, Genoa, Italy.; Dipartimento di Medicina Interna e Specialità Mediche (Di.M.I.), Università di Genova, Genoa, Italy., Biasi O; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Seitz RS; Oncocyte Corporation, Irvine, CA, USA., Valagussa P; Fondazione Michelangelo, Milan, Italy., Viale G; IEO, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.; University of Milan, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy., Bianchini G; Fondazione Michelangelo, Milan, Italy. bianchini.giampaolo@hsr.it.; San Raffaele Hospital, Milan, Italy. bianchini.giampaolo@hsr.it., Ali HR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. raza.ali@cruk.cam.ac.uk.; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK. raza.ali@cruk.cam.ac.uk.
Publikováno v:
Nature [Nature] 2023 Sep; Vol. 621 (7980), pp. 868-876. Date of Electronic Publication: 2023 Sep 06.
Autor:
Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Mariani M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Rossari F; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy., Viale G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Notini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Naldini MM; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy., Bosi C; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Piras M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: bianchini.giampaolo@hsr.it.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2023 Jun; Vol. 69, pp. 330-341. Date of Electronic Publication: 2023 Mar 27.
Autor:
Castagnoli L; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Corso S; Department of Oncology, University of Torino, Candiolo, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Franceschini A; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133, Milan, Italy., Bellomo SE; Department of Oncology, University of Torino, Candiolo, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Dugo M; Department of Medical Oncology-Breast Cancer Unit Clinical Translational and Immunotherapy Research, IRCCS Ospedale San Raffaele, Milan, Italy., Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133, Milan, Italy., Prisciandaro M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133, Milan, Italy., Brich S; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Belfiore A; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Vingiani A; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133, Milan, Italy., Pruneri G; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Giordano S; Department of Oncology, University of Torino, Candiolo, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, 20133, Milan, Italy. filippo.pietrantonio@istitutotumori.mi.it., Pupa SM; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. serenella.pupa@istitutotumori.mi.it.
Publikováno v:
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2023 Jun; Vol. 46 (3), pp. 661-676. Date of Electronic Publication: 2023 Feb 08.
Autor:
Rizzello C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy., Sangaletti S; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Ratti C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Milani M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Via F. Chiesa 5, 6500, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Ente Ospedialiero Cantonale, Via A. Gallino 12, 6500, Bellinzona, Switzerland., Tripodo C; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy.; FIRC Institute of Molecular Oncology (IFOM), Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. claudia.chiodoni@istitutotumori.mi.it., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. mariopaolo.colombo@istitutotumori.mi.it.
Publikováno v:
Molecular cancer [Mol Cancer] 2022 Dec 12; Vol. 21 (1), pp. 215. Date of Electronic Publication: 2022 Dec 12.
Autor:
Ligorio F; Metabolic Reprogramming in Solid Tumors Unit, IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Cosimo S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pizzamiglio S; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Castagnoli L; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy., Galbardi B; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Loi S; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Michiels S; Department of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Triulzi T; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., El-Abed S; Breast International Group (BIG), Brussels, Belgium., Izquierdo M; Novartis Pharma AG, Basel, Switzerland., de Azambuja E; Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium., Nuciforo P; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Huober J; Breast Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Moscetti L; Department of Oncology-Hematology, University Hospital of Modena, Modena, Italy.; Gruppo Oncologico Italiano per la Ricerca Clinica, Parma, Italy., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Coccia-Portugal MA; Clinical Trial Department, Eastleigh Breast Care Center, Pretoria, South Africa., Corsetto PA; Department of Pharmacology and Biomolecular Science, University of Milan, Milan, Italy., Belfiore A; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lorenzini D; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Daidone MG; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vingiani A; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy., Pupa SM; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchini G; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.; Breast Cancer Unit - Department of Medical Oncology, Università Vita-Salute San Raffaele, Milan, Italy., Pruneri G; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Vernieri C; Metabolic Reprogramming in Solid Tumors Unit, IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Dec 08; Vol. 114 (12), pp. 1720-1727.